Neoadjuvant Chemotherapy Plus Camrelizumab for FIGO Stage IB1 Cervical Cancer

Clinical trial NCT06289062 · RECRUITING

Trial details

NCT number: NCT06289062
Sponsor: Tongji Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Cervical Cancer Neoadjuvant Chemoimmunotherapy Fertility Preservation

Start date: 2024-05-08
Primary completion: 2025-12-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.